FDA Inspection 1179812 — Vanderbilt University Medical Center Human Research Protections Program
The FDA completed an inspection of Vanderbilt University Medical Center Human Research Protections Program on Sep 1, 2022 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 1, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
IRB